BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 3532703)

  • 1. Cell surface adenosine deaminase (ADA) and its complexing protein (ADCP) in human T-lymphoid cells.
    Dinjens WN; van der Boon J; ten Kate J; Zeijlemaker WP; De Bruijn CH; Bosman FT; Khan PM
    Adv Exp Med Biol; 1986; 195 Pt B():407-14. PubMed ID: 3532703
    [No Abstract]   [Full Text] [Related]  

  • 2. Distribution of adenosine deaminase complexing protein (ADCP) in human tissues.
    Dinjens WN; ten Kate J; van der Linden EP; Wijnen JT; Khan PM; Bosman FT
    J Histochem Cytochem; 1989 Dec; 37(12):1869-75. PubMed ID: 2573631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of adenosine deaminase with differentiation of normal and leukemic T and B lymphocytes.
    Chechik BE; Schrader WP; Fernandes B; Sengupta S; Gelfand EW
    Ann N Y Acad Sci; 1985; 451():169-79. PubMed ID: 3935026
    [No Abstract]   [Full Text] [Related]  

  • 4. Adenosine deaminase in cell transformation. Biophysical manifestation of membrane dynamics.
    Porat N; Gill D; Parola AH
    J Biol Chem; 1988 Oct; 263(29):14608-11. PubMed ID: 2844778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 5'Nucleotidase and adenosine deaminase activities in human lymphocytes and lymphoblastoid cell lines.
    Dornand J; Bonnafous JC; Favero J; Gartner A; Mani JC
    Adv Exp Med Biol; 1984; 165 Pt B():261-6. PubMed ID: 6326503
    [No Abstract]   [Full Text] [Related]  

  • 6. Terminal deoxynucleotidyl transferase and adenosine deaminase in human lymphoblastoid cell lines.
    Coleman MS; Hutton JJ
    Exp Cell Res; 1975 Sep; 94(2):440-2. PubMed ID: 1081454
    [No Abstract]   [Full Text] [Related]  

  • 7. Adenosine deaminase complexing protein (ADCP) immunoreactivity in colorectal adenocarcinoma.
    ten Kate J; van den Ingh HF; Khan PM; Bosman FT
    Int J Cancer; 1986 Apr; 37(4):479-85. PubMed ID: 3957458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative changes in adenosine deaminase isoenzymes in human colorectal adenocarcinomas.
    ten Kate J; Wijnen JT; van der Goes RG; Quadt R; Griffioen G; Bosman FT; Khan PM
    Cancer Res; 1984 Oct; 44(10):4688-92. PubMed ID: 6147190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adenosine deaminase activity in chronic lymphocytic leukemia: evaluation of lymphocytic ADA during and after treatment.
    Liso V; Specchia G; Pavone V; Garribba P; Riezzo A; Ferrannini A
    Haematologica; 1983; 68(4):487-94. PubMed ID: 6414899
    [No Abstract]   [Full Text] [Related]  

  • 10. Immunohistochemical localization of adenosine deaminase complexing protein in intestinal mucosa and in colorectal adenocarcinoma as a marker for tumour cell heterogeneity.
    Ten Kate J; Wijnen JT; Boldewijn J; Khan PM; Bosman FT
    Histochem J; 1985 Jan; 17(1):23-31. PubMed ID: 2859262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence for receptor-mediated uptake of adenosine deaminase in rabbit kidney.
    Schrader WP; Miczek AD; West CA; Samsonoff WA
    J Histochem Cytochem; 1988 Dec; 36(12):1481-7. PubMed ID: 2461411
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human adenosine deaminase. Properties and turnover in cultured T and B lymphoblasts.
    Daddona PE
    J Biol Chem; 1981 Dec; 256(23):12496-501. PubMed ID: 6975278
    [No Abstract]   [Full Text] [Related]  

  • 13. CD26, adenosine deaminase, and adenosine receptors mediate costimulatory signals in the immunological synapse.
    Pacheco R; Martinez-Navio JM; Lejeune M; Climent N; Oliva H; Gatell JM; Gallart T; Mallol J; Lluis C; Franco R
    Proc Natl Acad Sci U S A; 2005 Jul; 102(27):9583-8. PubMed ID: 15983379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selectively increased adenosine deaminase levels in T cells during typhoid fever.
    Nardiello S; Russo M; Pizzella T; Galanti B
    J Clin Lab Immunol; 1984 Jun; 14(2):103-5. PubMed ID: 6611417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Solid-phase adsorption of antigens for efficient production of antibodies reactive with native and fixed tissue antigens.
    Dinjens WN; Van der Linden EP; Signet CM; Wijnen JT; Meera Khan P; Ten Kate J; Bosman FT
    J Immunol Methods; 1990 Feb; 126(2):175-82. PubMed ID: 2406345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adenosine deaminase activity of normal lymphocytes and leukemic cells.
    Ben-Bassat I; Simoni F; Holtzman F; Ramot B
    Isr J Med Sci; 1979 Nov; 15(11):925-7. PubMed ID: 118945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adenosine deaminase activity in chronic lymphocytic leukemia. Relationship to B- and T-cell subpopulations.
    Tung R; Silber R; Quagliata F; Conklyn M; Gottesman J; Hirschhorn R
    J Clin Invest; 1976 Mar; 57(3):756-61. PubMed ID: 1082452
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Localization of adenosine deaminase and adenosine deaminase complexing protein in rabbit heart. Implications for adenosine metabolism.
    Schrader WP; West CA
    Circ Res; 1990 Mar; 66(3):754-62. PubMed ID: 1689616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heterogeneity of adenosine deaminase activity in neoplastics T-cells.
    Okamura J; Ikuno Y; Tasaka H; Mitsui T; Kikuchi M
    Lancet; 1980 Aug; 2(8192):486-7. PubMed ID: 6106135
    [No Abstract]   [Full Text] [Related]  

  • 20. The binding site of human adenosine deaminase for CD26/Dipeptidyl peptidase IV: the Arg142Gln mutation impairs binding to cd26 but does not cause immune deficiency.
    Richard E; Arredondo-Vega FX; Santisteban I; Kelly SJ; Patel DD; Hershfield MS
    J Exp Med; 2000 Nov; 192(9):1223-36. PubMed ID: 11067872
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.